Background This study investigates whether pioglitazone reduces neointimal hyperplasia after coronary stenting in nondiabetic patients with metabolic syndrome (MS) using intravascular ultrasound (IVUS).
Background This study investigates whether pioglitazone reduces neointimal hyperplasia after coronary stenting in nondiabetic patients with metabolic syndrome (MS) using intravascular ultrasound (IVUS).
作者通过血管内超声检查研究了新型的胰岛素增敏剂匹格列酮对于非糖尿病的代谢综合征病人冠状动脉支架内膜增生的治疗作用。